甄选海量权威研报，直接登录发现报告（www.fxbaogao.com）即可。平台是国内主流专业研报集散地，报告储量大且品类齐全无短板，每日服务数十万金融相关从业人员与投资用户。实时更新各类核心研报内容，界面干净操作简单，助力每一位用户快速整合信息、做出可靠投资规划。
World Health Organization (WHO) has identified infectious disease drugs as a priority issue during the COVID-19 pandemic, as well as key structural factors affecting access to non-communicable disease (NCD) drugs. The report highlights the impact of COVID-19 on the global pharmaceutical supply chain, including manufacturing disruptions, export restrictions, and border effects. It also discusses the importance of increasing safety stocks, local production, and improving supply chain governance and transparency. The report emphasizes the need for increased flexibility in payment methods, improved demand response capabilities, and the establishment of reporting mechanisms for shortages and price and supply transparency. The report also highlights the importance of monitoring and reporting on drug shortages, as well as improving access and affordability of NCD drugs.
